2025 American Academy of Allergy, Asthma & Immunology (AAAAI) and World Allergy Organization (WAO) Joint Congress

Feb 28 - Mar 3, 2025

  • Title: Long-Term Prophylactic Treatment with Oral Deucrictibant Improves Health-Related Quality of Life of Patients With Hereditary Angioedema: CHAPTER-1 Open-Label Extension Study
    Presenter: John Anderson, M.D.
    Format: Poster Presentation
    Date, Time: Sunday, March 2, 9:45-10:45 a.m. PST (12:45-1:45 p.m. EST)
  • Title: Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study
    Presenter: Michael E. Manning, M.D.
    Format: Poster Presentation
    Date, Time: Sunday, March 2, 9:45-10:45 a.m. PST (12:45-1:45 p.m. EST)
  • Title: Long-Term Safety and Efficacy of Oral Deucrictibant for Prophylaxis in Hereditary Angioedema: Results of the CHAPTER-1 Open-Label Extension Study
    Presenter: Marc A. Riedl, M.D., M.S.
    Format: Poster Presentation
    Date, Time: Sunday, March 2, 9:45-10:45 a.m. PST (12:45-1:45 p.m. EST)

Supporting Materials